Search research articles
Contact Us
Filters
Showing results (251-260 of 275) with videos related to
Page
of 28
Sort By:
Journal of the American Academy of Dermatology
|
March 12, 2005
Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata
Gary S Chuang, Amalia Martinez-Mir, Adam Geyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2010
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
A M Evens, B D Jovanovic, Y-C Su, et al.
Leukemia
|
February 13, 2013
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype
S-Y Tan, S-S Chuang, T Tang, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1alpha,25-dihydroxyvitamin D3
Gary H Posner, Kenneth R Crawford, Hong Woon Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2012
Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis
H K Ahn, C Suh, S S Chuang, et al.
Human Mutation
|
January 22, 2008
Myoclonus-dystonia: significance of large SGCE deletions
A Grünewald, A Djarmati, K Lohmann-Hedrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2017
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma
Y L Kwong, S J Kim, E Tse, et al.
Leukemia
|
February 9, 2016
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma
M-L Nairismägi, J Tan, J Q Lim, et al.
Journal of Clinical Medicine
|
November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial
Michael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Physical Review Letters
|
November 5, 2004
Measurement of the tt production cross section in pp collisions at sqrt[s]=1.96 TeV using dilepton events
D Acosta, T Affolder, T Akimoto, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 275) with videos related to
Sort By:
Page
of 28
Journal of the American Academy of Dermatology
|
March 12, 2005
Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata
Gary S Chuang, Amalia Martinez-Mir, Adam Geyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2010
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
A M Evens, B D Jovanovic, Y-C Su, et al.
Leukemia
|
February 13, 2013
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype
S-Y Tan, S-S Chuang, T Tang, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
July 1, 2004
Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-sulfone analogs of the hormone 1alpha,25-dihydroxyvitamin D3
Gary H Posner, Kenneth R Crawford, Hong Woon Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2012
Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis
H K Ahn, C Suh, S S Chuang, et al.
Human Mutation
|
January 22, 2008
Myoclonus-dystonia: significance of large SGCE deletions
A Grünewald, A Djarmati, K Lohmann-Hedrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2017
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma
Y L Kwong, S J Kim, E Tse, et al.
Leukemia
|
February 9, 2016
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma
M-L Nairismägi, J Tan, J Q Lim, et al.
Journal of Clinical Medicine
|
November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial
Michael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Physical Review Letters
|
November 5, 2004
Measurement of the tt production cross section in pp collisions at sqrt[s]=1.96 TeV using dilepton events
D Acosta, T Affolder, T Akimoto, et al.
Page
of 28